Skye Bioscience, Stock Target Price and Analyst Consensus
| SKYE Stock | USD 2.86 0.15 4.98% |
The current analyst and expert consensus on Skye Bioscience, is Strong Buy, with 3 strong buy opinions. The current projected Skye Bioscience, target price consensus is 18.25 with 6 analyst opinions. Check out Macroaxis Advice on Skye Bioscience, to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Skye Bioscience, Common analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Skye Bioscience, executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Skye Bioscience,. We strongly encourage you to use your own analysis of Skye Bioscience, Common to validate this buy or sell advice. Skye Bioscience, buy-or-sell recommendation module provides average expert sentiment on the projected Skye Bioscience, Common target price to derive its highest and lowest estimates based on projected price volatility of 5.2894.
Lowest Forecast 16.61 | Highest Forecast 20.26 | Target Price 18.25 |
Skye |
It's important to approach Skye Bioscience,'s target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Skye Bioscience, price targets
Skye Bioscience,'s stock target price is an estimate of its future price, usually made by analysts. Using Skye Bioscience,'s target price to determine if it is a suitable investment can be done through the following steps:- Look at Skye Bioscience,'s target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Skye Bioscience,'s stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Skye Bioscience, Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Skye Bioscience, is a key component of Skye Bioscience, valuation and have some predictive power on the future returns of a Skye Bioscience,.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Skye Bioscience,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Banking Invested over 40 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Investor Favorites Invested over 200 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Business Services Invested few shares | |
 | Social Domain Invested few shares | |
 | Impulse Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Millennials Best Invested few shares | |
 | Technology Invested few shares | |
 | Blockchain Invested few shares | |
Check out Macroaxis Advice on Skye Bioscience, to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Please note, the presentation of Skye Bioscience,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Skye Bioscience,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Skye Bioscience,'s management manipulating its earnings.